Table 1. Monitoring intervals for people with COAG (adapted from NICE glaucoma guidelines).
|
Clinical assessment |
Number of patients |
NICE recommended monitoring interval (months) |
Monitoring interval requested by clinician (months) | |||
|---|---|---|---|---|---|---|
| Group number | IOP at targeta | Progressionb | IOP alone | IOP, optic nerve head, visual field | ||
| 1 | Yes | Noc | 23 | Not applicable | 6–12 | Mean 6.9±2.3 |
| Range 4–12 | ||||||
| 2 | Yes | Yes | 2 | 1–4 | 2–6 | Mean 2.0±0 |
| 3 | Yes | Uncertain | 5 | Not applicable | 2–6 | Mean 4.8±1.8 |
| Range 4–8 | ||||||
| 4 | No | Noc | 7 | 1–4 | 6–12 | Mean 3.0±2 |
| Range 2–6 | ||||||
| 5 | No | Yes/uncertain | 17 | 1–2 | 2–6 | Mean 2.0±0.8 |
| Range 1 week to 6 months | ||||||
a
IOP at or below target.
b
Progression, increased optic nerve damage and/or visual field change confirmed by repeated test where clinically appropriate.
c
No, not detected or not assessed if IOP check only following treatment change.